The cephalosporins: activity and clinical use.
The cephalosporin antibiotics have been employed with increasing frequency since their introduction into clinical practice in the early 1960s. With the exception of cephaloridine, cephalosporin compounds are not associated with the production of significant untoward effects. The availability of newer cephalosporins, both oral and parenteral, with enhanced antibacterial activity, has expanded the clinical indications for administration of these antibiotics.
D002433:Cefaclor / Q000494:pharmacology; D002435:Cefamandole / Q000494:pharmacology; D002436:Cefatrizine / Q000494:pharmacology; D002437:Cefazolin / Q000494:pharmacology; D002440:Cefoxitin / Q000494:pharmacology; D002444:Cefuroxime / Q000494:pharmacology; D002505:Cephacetrile / Q000494:pharmacology; D002506:Cephalexin / Q000494:pharmacology; D002507:Cephaloglycin / Q000494:pharmacology; D002509:Cephaloridine / Q000494:pharmacology; D002511:Cephalosporins / Q000494:pharmacology* / Q000627:therapeutic use; D002512:Cephalothin / Q000494:pharmacology; D002514:Cephapirin / Q000494:pharmacology; D004342:Drug Hypersensitivity; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced
D002511:Cephalosporins; D002435:Cefamandole; D002433:Cefaclor; D002440:Cefoxitin; D002514:Cephapirin; D002436:Cefatrizine; D002505:Cephacetrile; D002437:Cefazolin; D002509:Cephaloridine; D002507:Cephaloglycin; D002444:Cefuroxime; D002506:Cephalexin; D002512:Cephalothin